CEST is a novel MR technique helpful for predicting IDH and 1p/19q status in gliomas. The asymmetry-based methods however are sensitive to fluid signal and recent studies have shown that a significant proportion of IDH-mutant 1p/19q retained gliomas have T2-FLAIR mismatch, indicating the presence of a more fluid microenvironment. This work shows how fluid-suppressed CEST imaging metrics have an impact on amide and amine signals in glioma, with highest effect on IDH-mutant 1p/19q retained with T2-FLAIR mismatch. The combined use of asymmetry-based and fluid-suppressed CEST metrics could be a valuable tool for glioma staging more robust than asymmetry-based metrics alone.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords